Maryam Mohammadi-Khanaposhtani

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Venues

Archiv der Pharmazie

RSC advances

Journal of diabetes and metabolic disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Shirin Ansariashlaghi, Azadeh Fakhrioliaei, Maryam Mohammadi-Khanaposhtani, Milad Noori, Mehdi Asadi, Somayeh Mojtabavi, Mohammad A Faramarzi, Ensieh N Esfahani, Hossein Rastegar, Bagher Larijani, Homa Azizian, Mohammad Mahdavi
New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes. Archiv der Pharmazie 357 (7) (2024)
Shirin Ansariashlaghi, Azadeh Fakhrioliaei, Maryam Mohammadi-Khanaposhtani, Milad Noori, Mehdi Asadi, Somayeh Mojtabavi, Mohammad A Faramarzi, Ensieh N Esfahani, Hossein Rastegar, Bagher Larijani, Homa Azizian, Mohammad Mahdavi
New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes. Archiv der Pharmazie 357 (7) (2024)
Shirin Ansariashlaghi, Azadeh Fakhrioliaei, Maryam Mohammadi-Khanaposhtani, Milad Noori, Mehdi Asadi, Somayeh Mojtabavi, Mohammad A Faramarzi, Ensieh N Esfahani, Hossein Rastegar, Bagher Larijani, Homa Azizian, Mohammad Mahdavi
New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes. Archiv der Pharmazie (2024)
Nafiseh Zare, Fatemeh Bandarian, Ensieh Nasli Esfahani, Bagher Larijani, Mohammad Mahdavi, Maryam Mohammadi-Khanaposhtani, Hossein Najafzadehvarzi
In vivo and in silico evaluations of a synthetic pyrano[3,2-c]quinoline derivative as a potent anti-diabetic agent. Journal of diabetes and metabolic disorders 23 (1) (2023)
Sajedeh Safapoor, Mohammad Halimi, Minoo Khalili Ghomi, Milad Noori, Navid Dastyafteh, Shahrzad Javanshir, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Ensieh Nasli-Esfahani, Bagher Larijani, Azadeh Fakhrioliaei, Mohammad G Dekamin, Maryam Mohammadi-Khanaposhtani, Mohammad Mahdavi
Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides. RSC advances 13 (28) (2023)
Sajedeh Safapoor, Mohammad Halimi, Minoo Khalili Ghomi, Milad Noori, Navid Dastyafteh, Shahrzad Javanshir, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Ensieh Nasli-Esfahani, Bagher Larijani, Azadeh Fakhrioliaei, Mohammad G Dekamin, Maryam Mohammadi-Khanaposhtani, Mohammad Mahdavi
Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides. RSC advances 13 (28) (2023)
Sajedeh Safapoor, Mohammad Halimi, Minoo Khalili Ghomi, Milad Noori, Navid Dastyafteh, Shahrzad Javanshir, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Ensieh Nasli-Esfahani, Bagher Larijani, Azadeh Fakhrioliaei, Mohammad G Dekamin, Maryam Mohammadi-Khanaposhtani, Mohammad Mahdavi
Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides. RSC advances 13 (28) (2023)
Nafiseh Zare, Fatemeh Bandarian, Ensieh Nasli Esfahani, Bagher Larijani, Mohammad Mahdavi, Maryam Mohammadi-Khanaposhtani, Hossein Najafzadehvarzi
In vivo and in silico evaluations of a synthetic pyrano[3,2-c]quinoline derivative as a potent anti-diabetic agent. Journal of diabetes and metabolic disorders 23 (1) (2023)
Samira Ansari, Homa Azizian, Keyvan Pedrood, Ali Yavari, Somayeh Mojtabavi, Mohammad A Faramarzi, Shiva Golshani, Samanesadat Hosseini, Mahmood Biglar, Bagher Larijani, Hossein Rastegar, Haleh Hamedifar, Maryam Mohammadi-Khanaposhtani, Mohammad Mahdavi
Design, synthesis, and α-glucosidase-inhibitory activity of phenoxy-biscoumarin-N-phenylacetamide hybrids. Archiv der Pharmazie 354 (12) (2021)

Maryam Mohammadi-Khanaposhtani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maryam Mohammadi-Khanaposhtani